ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
66,847.96
-0.35%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ABVC BioPharma Inc (ABVC)

  7. ABVC BioPharma Inc (ABVC) News

ABVC

ABVC BioPharma (ABVC)

ABVC BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABVC
DateTimeSourceHeadlineSymbolCompany
05/17/20244:00PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ABVCABVC BioPharma Inc
05/17/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABVCABVC BioPharma Inc
05/15/20244:00PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ABVCABVC BioPharma Inc
05/15/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
05/09/20248:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
04/18/20248:25AMGlobeNewswire Inc.AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per ShareNASDAQ:ABVCABVC BioPharma Inc
04/17/20248:00AMGlobeNewswire Inc.ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50MNASDAQ:ABVCABVC BioPharma Inc
04/10/20247:30AMGlobeNewswire Inc.ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50MNASDAQ:ABVCABVC BioPharma Inc
03/26/20247:30AMGlobeNewswire Inc.ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60MNASDAQ:ABVCABVC BioPharma Inc
03/21/20247:30AMGlobeNewswire Inc.AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million DollarsNASDAQ:ABVCABVC BioPharma Inc
03/19/20247:30AMGlobeNewswire Inc.ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia MagazineNASDAQ:ABVCABVC BioPharma Inc
03/14/20248:30AMGlobeNewswire Inc.ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business UpdateNASDAQ:ABVCABVC BioPharma Inc
02/29/20243:32PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ABVCABVC BioPharma Inc
02/29/20243:31PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ABVCABVC BioPharma Inc
02/27/20247:30AMGlobeNewswire Inc.ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion DollarsNASDAQ:ABVCABVC BioPharma Inc
02/16/20244:04PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ABVCABVC BioPharma Inc
02/15/20247:30AMGlobeNewswire Inc.ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future RevenuesNASDAQ:ABVCABVC BioPharma Inc
02/13/20246:59PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABVCABVC BioPharma Inc
02/12/20247:30AMGlobeNewswire Inc.ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)NASDAQ:ABVCABVC BioPharma Inc
02/09/20244:04PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ABVCABVC BioPharma Inc
02/08/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
02/08/20248:17AMGlobeNewswire Inc.ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per ShareNASDAQ:ABVCABVC BioPharma Inc
01/17/20244:01PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ABVCABVC BioPharma Inc
01/17/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
01/17/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
01/12/20244:01PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ABVCABVC BioPharma Inc
01/03/20246:24AMGlobeNewswire Inc.ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing FeesNASDAQ:ABVCABVC BioPharma Inc
12/07/20237:30AMGlobeNewswire Inc.ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical StudyNASDAQ:ABVCABVC BioPharma Inc
12/05/20237:30AMGlobeNewswire Inc.ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical TrialsNASDAQ:ABVCABVC BioPharma Inc
11/21/20237:30AMGlobeNewswire Inc.ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion MarketNASDAQ:ABVCABVC BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABVC

Your Recent History

COIN
GHUBUST
GemHUB
EU
J324S
J324S
AMEX
FXC
Invesco CurrencyShares C...
EU
A237S
A237S
NASDAQI
OMXCCAPNI
OMX Copenhagen CAP NI
LSE
BRDY
COIN
ICAUST
Icarus
BIT
UB7RUD
Unicredit Bank
BIT
UV4L84
UniCredit Bank
BTHB
LPTKRW
Livepeer Token
COIN
ORNETH
Orion Protocol
COIN
SFTTUST
SFT
BIT
UV4M0C
UniCredit Bank
BMF
FRCN27
FRCN27 - 07/2027
COIN
ELLAUSD
NASDAQ
REPH
Recro Pharma
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved